Accendra Health reported third quarter 2025 results.

Item 2.02 Results of Operations and Financial Condition.

On October 30, 2025, Owens & Minor, Inc. (the "Company") issued a press release² regarding its financial results for the third quarter and nine months ended September 30, 2025. The Company is furnishing the press release attached hereto as Exhibit 99.1¹ pursuant to Item 2.02 of Form 8-K. In accordance with General Instruction B.2 of Form 8-K, the information in this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

Item 7.01 Regulation FD Disclosure.

On October 30, 2025, the Company posted an earnings presentation on the Investor Relations section of its website. The Company is furnishing the earnings presentation attached hereto as Exhibits 99.2¹ pursuant to Item 7.01 of Form 8-K. In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01, including Exhibit 99.2, shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

99.1

Press Release issued by the Company on October 30 , 2025, announcing third quarter results (furnished pursuant to Item 2.02)

99.2

Earnings Presentation dated October 30 , 2025 (furnished pursuant to Item 7.01)

104

Cover Page Interactive Data File (the cover page XBRL tags are embedded in the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

OWENS & MINOR, INC.

Date: October 30 , 2025

By:

/s/ Heath H. Galloway

Name:

Heath H. Galloway

Title:

Executive Vice President, General Counsel and Corporate Secretary

Owens & Minor Reports Third Quarter 2025 Financial Results³

Signed Definitive Agreement for the Sale of Products & Healthcare Services Segment³

Transaction Positions the Company as a Pure-Play Home-Based Care Business

RICHMOND, VA – October 30, 2025 – Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the third quarter ended September 30, 2025. Unless otherwise noted, the results herein reflect the Company's continuing operations, which primarily represent what was previously the Patient Direct segment and certain functional operations.

"Our recent announcement on the sale of our Products & Healthcare Services segment is another meaningful step in our strategy to pivot our focus to the more attractive home-based care space. We are keenly focused on reshaping our organization as one built around our Patient Direct platform and the long-term growth opportunities within home-based care. An example of this focus on growth is our recently announced nationwide preferred provider partnership agreement⁴," said Edward A. Pesicka, President & Chief Executive Officer, Owens & Minor⁵.

"Looking ahead, we will be a simpler, stronger company that is better positioned to execute on our